[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100555821":3},{"organization":4,"armGroups":7,"interventions":28,"overallOfficials":27,"centralContacts":36,"locations":42,"responsibleParty":62,"collaborators":27,"id":66,"slug":67,"hasResults":68,"nctId":69,"briefTitle":70,"officialTitle":71,"acronym":27,"eligibilityCriteria":72,"healthyVolunteers":73,"sex":74,"minAge":75,"maxAge":76,"enrollmentInfo":77,"targetDuration":27,"studyType":80,"phases":81,"briefSummary":83,"conditions":84,"keywords":27,"overallStatus":45,"whyStopped":27,"lastUpdateSubmitDate":86,"lastUpdatePostDateStruct":87,"startDateStruct":90,"completionDateStruct":92,"leadSponsor":94,"locationsCount":95},{"fullName":5,"class":6},"Yangzhou University","OTHER",[8,15,19,23],{"label":9,"type":10,"description":11,"interventionNames":12},"TEAS combined with Oxycodone","EXPERIMENTAL","Bilateral Neiguan point (PC6), Zusanli point (ST36) and Sanyinjiao point (SP6) were selected. Use Huatuo electronic needle therapy device, Sulodine electric stimulation hand circle TEAS, Huatuo electronic needle therapy device parameter setting: Density wave, 2\u002F10Hz, current intensity from weak to strong, until the patient can tolerate the maximum intensity (acid, numbness, distension, pain) is appropriate, after the Sulodine brand electrical stimulation bracelet is turned on, gradually increase the stimulation intensity, until the patient can tolerate the maximum intensity is appropriate, stimulation for 30min until anesthesia induction; Oxycodone 0.1mg\u002Fkg was injected intravenously 5 minutes before anesthesia induction",[13,14],"Other: TEAS","Drug: Oxycodone",{"label":16,"type":10,"description":17,"interventionNames":18},"TEAS","Bilateral Neiguan point (PC6), Zusanli point (ST36) and Sanyinjiao point (SP6) were selected. Use Huatuo electronic needle therapy device, Sulodine electric stimulation hand circle TEAS, Huatuo electronic needle therapy device parameter setting: Density wave, 2\u002F10Hz, current intensity from weak to strong, until the patient can tolerate the maximum intensity (acid, numbness, distension, pain) is appropriate, after the Sulodine brand electrical stimulation bracelet is turned on, gradually increase the stimulation intensity, until the patient can tolerate the maximum intensity is appropriate, stimulation for 30min until anesthesia induction; The same amount of normal saline was injected intravenously 5 minutes before anesthesia induction.",[13],{"label":20,"type":10,"description":21,"interventionNames":22},"Oxycodone","Bilateral Neiguan point (PC6), Zusanli point (ST36) and Sanyinjiao point (SP6) were selected. Stick electrodes only but do not stimulate; Oxycodone 0.1mg\u002Fkg was injected intravenously 5 minutes before anesthesia induction",[14],{"label":24,"type":25,"description":26,"interventionNames":27},"Comparator","NO_INTERVENTION","Bilateral Neiguan point (PC6), Zusanli point (ST36) and Sanyinjiao point (SP6) were selected. Stick electrodes only but do not stimulate; The same amount of normal saline was injected intravenously 5 minutes before anesthesia induction.",null,[29,32],{"type":6,"name":16,"description":30,"armGroupLabels":31,"otherNames":27},"Bilateral Neiguan point (PC6), Zusanli point (ST36) and Sanyinjiao point (SP6) were selected. Use Huatuo electronic needle therapy device, Sulodine electric stimulation hand circle TEAS, Huatuo electronic needle therapy device parameter setting: Density wave, 2\u002F10Hz, current intensity from weak to strong, until the patient can tolerate the maximum intensity (acid, numbness, distension, pain) is appropriate, after the Sulodine brand electrical stimulation bracelet is turned on, gradually increase the stimulation intensity, until the patient can tolerate the maximum intensity is appropriate, stimulation for 30min until anesthesia induction",[16,9],{"type":33,"name":20,"description":34,"armGroupLabels":35,"otherNames":27},"DRUG","Oxycodone 0.1mg\u002Fkg was injected intravenously 5 minutes before anesthesia induction",[20,9],[37],{"name":38,"role":39,"phone":40,"phoneExt":27,"email":41},"Meiyu Liu","CONTACT","+86 177 6198 0727","myliu@yzu.edu",[43],{"facility":44,"status":45,"city":46,"state":47,"zip":48,"country":49,"countryCode":50,"cosmosGeoPoint":51,"geoPoint":56,"contacts":57},"Affiliated Hospital of Yangzhou University","RECRUITING","Yangzhou","Jiangsu","225000","China","CN",{"type":52,"coordinates":53},"Point",[54,55],119.43583,32.39722,{"lat":55,"lon":54},[58],{"name":59,"role":39,"phone":60,"phoneExt":27,"email":61},"Liu Meiyu, Director","17761980727","meiyuliu@yzu.edu.cn",{"type":63,"investigatorFullName":64,"investigatorTitle":65,"investigatorAffiliation":5,"oldNameTitle":27,"oldOrganization":27},"PRINCIPAL_INVESTIGATOR","Wang wanxia","Principal Investigator","100555821","effect-of-teas-combined-with-oxycodone-on-postoperative-visceral-pain-in-gynecologic-laparoscopic-patients-100555821",false,"NCT06517069","Effect of TEAS Combined With Oxycodone on Postoperative Visceral Pain in Gynecologic Laparoscopic Patients","Effect of Transcutaneous Electrical Acupoint Stimulation Combined With Oxycodone on Postoperative Visceral Pain and Early Recovery Quality in Gynecologic Laparoscopic Patients","Inclusion Criteria:\n\n* Age 18-65 years\n* American Society of Anesthesiologists grade I-II\n* Body mass index (BMI) 18.5-30 kg\u002Fm2;\n* No ulceration or infection at the acupuncture stimulation site.\n\nExclusion Criteria:\n\n* Allergic to the drugs used in the study;\n* People with unclear consciousness or cognitive dysfunction;\n* There are contraindications of percutaneous acupoint electrical stimulation;\n* Abnormal cardiopulmonary and liver and kidney function;\n* History of analgesic drug use within one week;\n* History of diabetes, myocardial infarction or cerebrovascular accident.",true,"FEMALE","18 Years","65 Years",{"count":78,"type":79},120,"ESTIMATED","INTERVENTIONAL",[82],"NA","To investigate the effect and feasibility of percutaneous acupoint stimulation combined with oxycodone on postoperative visceral pain in laparoscopic patients, and provided a clinical basis for optimizing perioperative pain management in laparoscopic patients.",[85],"Visceral Pain","2024-07-27",{"date":88,"type":89},"2024-07-30","ACTUAL",{"date":91,"type":89},"2024-05-01",{"date":93,"type":79},"2025-07-01",{"name":5,"class":6},1]